Skip to content

Infectious Disease

National Jewish Health was founded in 1899 as a hospital to treat patients with tuberculosis infections. Since our inception, we have made groundbreaking discoveries in infectious disease research. Our physician-scientists were among the leaders in developing combined chemotherapy treatments for fighting tuberculosis. Here is an overview of our infectious disease research programs:

  • Non-Tuberculosis Mycobacterial (NTM) Lung Infection Research: Our research focuses on understanding and treating NTM infections in individuals with bronchiectasis. This research spans genetics, epidemiology, pathogenesis, diagnostics and treatment strategies.
  • Clinical Trials and Studies: Our physician-scientists conduct clinical trials to evaluate new and emerging treatments for pulmonary infections, aiming to improve patient outcomes and develop more effective therapies.
  • Infectious Disease Research Advancements: Developed the culture medium to grow tuberculosis. Combined chemotherapy for tuberculosis. Novel anti-viral lipid therapeutics against COVID and influenza virus.
  • Jamie Barr

    Jamie Barr, PhD

  • Hong Wei Chu

    Hong Wei Chu, MD

  • James L. Crooks

    James L. Crooks, PhD, MS

  • Charles L. Daley

    Charles L. Daley, MD

  • Brian J. Day

    Brian J. Day, PhD

  • Gregory P. Downey

    Gregory P. Downey, MD, FRCPC

  • Katherine Hisert

    Katherine Hisert, MD, PhD

  • Patrick S. Hume

    Patrick S. Hume, MD, PhD

  • Shannon H. Kasperbauer

    Shannon H. Kasperbauer, MD

  • Camille M. Moore

    Camille M. Moore, PhD

  • Jerry A. Nick

    Jerry A. Nick, MD

  • Mari Numata-Nakamura

    Mari Numata-Nakamura, MD, PhD

  • Cristina Penaranda

    Cristina Penaranda, PhD

  • Lilliana Radoshevich

    Lilliana Radoshevich, PhD

  • R. Lee Reinhardt

    R. Lee Reinhardt, PhD

  • Jeff Swigris

    Jeff Swigris, DO, MS

  • Elizabeth Wynn

    Elizabeth Wynn, PhD

  • Soonho Yoon

    Soonho Yoon, MD, PhD

  • Gongyi Zhang

    Gongyi Zhang, PhD